Matches in SemOpenAlex for { <https://semopenalex.org/work/W3212263103> ?p ?o ?g. }
- W3212263103 endingPage "9155" @default.
- W3212263103 startingPage "9139" @default.
- W3212263103 abstract "Immune-based combination therapies have revolutionized the first-line treatment for advanced non-small cell lung cancer (NSCLC). However, for the efficacy and safety, the best treatment option is still uncertain.We conducted a Bayesian network meta-analysis of randomized controlled trials (RCTs) to evaluate first-line immune-based combination therapies for advanced NSCLC.Fourteen trials involving 8467 patients were included. For the programmed cell death-ligand 1 (PD-L1) expression non-selective patients, there were no significant differences among all the treatment modes for overall survival (OS), but the ranking profiles indicated that Immunotherapy + Immunotherapy + Chemotherapy (IO + IO + Chemo) was most likely to be the best mode (probability = 68%). Immunotherapy + Immunotherapy + Anti-angiogenic therapy + Chemotherapy (IO + Anti-angio + Chemo) was significantly better than most other treatment modes for progression-free survival (PFS) with better objective response rate (ORR) and more obvious grade ≥3 treatment-related adverse events (TRAEs). In PD-L1-high cohort, IO + Anti-angio + Chemo seemed to be the best mode for OS, PFS, and ORR according to the ranking profiles. In PD-L1-intermediate and PD-L1-negative cohort, IO + IO + Chemo was inclined to be ranked first for prolonging OS (probability = 78%; 37%) and IO + Anti-angio + Chemo was most likely to provide best PFS (probability = 96%; 100%).IO + IO + Chemo has great potential to improve the OS regardless of histology type, especially in PD-L1-intermediate and PD-L1-negative cohort. IO + Anti-angio + Chemo shows great superiority in improving the short-term survival accompanied by increasing grade ≥3 TRAEs." @default.
- W3212263103 created "2021-11-22" @default.
- W3212263103 creator A5013196129 @default.
- W3212263103 creator A5015683388 @default.
- W3212263103 creator A5024016708 @default.
- W3212263103 creator A5035754451 @default.
- W3212263103 creator A5036505611 @default.
- W3212263103 creator A5039239707 @default.
- W3212263103 creator A5040267650 @default.
- W3212263103 creator A5042877710 @default.
- W3212263103 creator A5052318752 @default.
- W3212263103 creator A5070894152 @default.
- W3212263103 date "2021-11-07" @default.
- W3212263103 modified "2023-10-16" @default.
- W3212263103 title "First‐line immune‐based combination therapies for advanced non‐small cell lung cancer: A Bayesian network meta‐analysis" @default.
- W3212263103 cites W1617328014 @default.
- W3212263103 cites W1913780655 @default.
- W3212263103 cites W1996374378 @default.
- W3212263103 cites W2019236122 @default.
- W3212263103 cites W2097995306 @default.
- W3212263103 cites W2098923148 @default.
- W3212263103 cites W2123363005 @default.
- W3212263103 cites W2163351155 @default.
- W3212263103 cites W2222086386 @default.
- W3212263103 cites W2279684443 @default.
- W3212263103 cites W2528546798 @default.
- W3212263103 cites W2588681363 @default.
- W3212263103 cites W2589171490 @default.
- W3212263103 cites W2598590813 @default.
- W3212263103 cites W2602885066 @default.
- W3212263103 cites W2608165987 @default.
- W3212263103 cites W2625574648 @default.
- W3212263103 cites W2749408522 @default.
- W3212263103 cites W2753529762 @default.
- W3212263103 cites W2757666766 @default.
- W3212263103 cites W2760329426 @default.
- W3212263103 cites W2791328450 @default.
- W3212263103 cites W2807361338 @default.
- W3212263103 cites W2888031957 @default.
- W3212263103 cites W2888059202 @default.
- W3212263103 cites W2898605921 @default.
- W3212263103 cites W2911188335 @default.
- W3212263103 cites W2911831872 @default.
- W3212263103 cites W2914335731 @default.
- W3212263103 cites W2942467666 @default.
- W3212263103 cites W2944817662 @default.
- W3212263103 cites W2946386783 @default.
- W3212263103 cites W2981393199 @default.
- W3212263103 cites W2995826615 @default.
- W3212263103 cites W2998269674 @default.
- W3212263103 cites W3009099064 @default.
- W3212263103 cites W3015378603 @default.
- W3212263103 cites W3015859409 @default.
- W3212263103 cites W3017322331 @default.
- W3212263103 cites W3037506839 @default.
- W3212263103 cites W3043670251 @default.
- W3212263103 cites W3080088791 @default.
- W3212263103 cites W3088072011 @default.
- W3212263103 cites W3088116761 @default.
- W3212263103 cites W3089009365 @default.
- W3212263103 cites W3089095190 @default.
- W3212263103 cites W3092756800 @default.
- W3212263103 cites W3107908752 @default.
- W3212263103 cites W3212263103 @default.
- W3212263103 cites W4210992155 @default.
- W3212263103 cites W3088609693 @default.
- W3212263103 doi "https://doi.org/10.1002/cam4.4405" @default.
- W3212263103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34747149" @default.
- W3212263103 hasPublicationYear "2021" @default.
- W3212263103 type Work @default.
- W3212263103 sameAs 3212263103 @default.
- W3212263103 citedByCount "4" @default.
- W3212263103 countsByYear W32122631032021 @default.
- W3212263103 countsByYear W32122631032022 @default.
- W3212263103 countsByYear W32122631032023 @default.
- W3212263103 crossrefType "journal-article" @default.
- W3212263103 hasAuthorship W3212263103A5013196129 @default.
- W3212263103 hasAuthorship W3212263103A5015683388 @default.
- W3212263103 hasAuthorship W3212263103A5024016708 @default.
- W3212263103 hasAuthorship W3212263103A5035754451 @default.
- W3212263103 hasAuthorship W3212263103A5036505611 @default.
- W3212263103 hasAuthorship W3212263103A5039239707 @default.
- W3212263103 hasAuthorship W3212263103A5040267650 @default.
- W3212263103 hasAuthorship W3212263103A5042877710 @default.
- W3212263103 hasAuthorship W3212263103A5052318752 @default.
- W3212263103 hasAuthorship W3212263103A5070894152 @default.
- W3212263103 hasBestOaLocation W32122631031 @default.
- W3212263103 hasConcept C10515644 @default.
- W3212263103 hasConcept C121608353 @default.
- W3212263103 hasConcept C126322002 @default.
- W3212263103 hasConcept C143998085 @default.
- W3212263103 hasConcept C168563851 @default.
- W3212263103 hasConcept C197934379 @default.
- W3212263103 hasConcept C207103383 @default.
- W3212263103 hasConcept C2776256026 @default.
- W3212263103 hasConcept C2776694085 @default.
- W3212263103 hasConcept C2777701055 @default.
- W3212263103 hasConcept C44249647 @default.